Although the underlying mechanism of this phenomenon could not be assessed in this study, we speculate that hyperglycemia-induced upregulation of unfavorable molecules, such as plasma proinflammatory cytokines and advanced glycation end products, reduce the relative contributions of plasma VAP-1 to the incidence of CV events (36, 37). Here, AOC3 is linked to Hyperglycemia.